Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,075.00    -515.00 (-9.21%)
Bid:
5,060.00
Ask:
5,065.00
Spread: 5.00 (0.099%)
Market Cap: $1.33t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Charitable Contribution

30 Apr 2025 08:45

RNS Number : 8065G
Samsung Electronics Co. Ld
30 April 2025
 

Charitable Contribution

 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("SEC") on April 30, 2025, announced that its Board of Directors has authorized the following contributions.

 

Contributions for a fund to provide performance incentives to suppliers for SEC's Device Solutions ("DS") Division

- SEC will provide approximately KRW 38.6 billion for incentives to be distributed to qualified

 suppliers from the 181 first- and second-tier suppliers for the DS Division that are classified as

 SMEs and are stationed within the operations.

- The incentives aim to contribute to preventing worksite accidents, improving product quality, and

 expanding activities that encourage mutual cooperation with SEC's partners.

- Evaluations of supplier performances in the first half of 2025 will be conducted in August 2025; and evaluations for the second half of 2025 will be conducted in February 2026.

- Suppliers scoring above a certain rating will receive incentive payments from an available total of

 the estimated KRW 38.6 billion, which estimation is subject to change depending on evaluation

 results and management outcome of DS Division.

- SEC will contribute to "Large, Small-and-Medium Size Enterprises, Farming and Fishing Industries

 Cooperation Foundation," which will distribute the incentive to the eligible suppliers.

- The total estimated amount to be provided to all suppliers stationed within the DS Division

 operations is KRW 49.8 billion.

 

 

Donations to the Korean Red Cross to support the regions affected by the wildfires in Gyeongsang province and Ulsan

- SEC will have donated a total of KRW 1.85 billion in May 2025 to Korean Red Cross, which includes KRW 0.9 billion donated in March 28, 2025, to support the recovery of damaged areas in Gyeongsang province and Ulsan.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPKKBQOBKKNQN
Date   Source Headline
30th Jun 202210:01 amRNSSustainability Report 2022
31st May 202211:43 amRNSCorporate Governance Report FY2021
31st May 202211:02 amRNS2022 1Q Interim Business Report
18th May 202210:26 amRNSEarly Termination of Independent Director’s Term
29th Apr 20222:50 pmRNS2021 Business Report
28th Apr 202210:01 amRNSTransactions with Affiliated Companies
28th Apr 20229:49 amRNSTransactions with Affiliated Companies
28th Apr 20229:44 amRNSCharitable Contribution
28th Apr 20229:29 amRNSQuarterly Dividend for First Quarter 2022
28th Apr 20229:24 amRNS2022 1Q Earnings Release
21st Apr 20229:18 amRNSEarly Termination of Independent Director’s Term
21st Apr 20228:49 amRNSEarly Termination of Independent Director’s Term
7th Apr 20229:35 amRNSNotice of 1Q 2022 Earnings Release Schedule
7th Apr 20229:32 amRNS1Q 2022 Pre-Earnings Guidance
16th Mar 20229:10 amRNSTransaction with Affiliate Company
16th Mar 20229:08 amRNSAppointment of New Chief Executive Officer
16th Mar 20229:06 amRNSResults of the 53rd Annual General Meeting
17th Feb 202210:18 amRNSReference Material for 2022 AGM
17th Feb 20228:40 amRNS2021 Separate Financial Statements
17th Feb 20228:30 amRNS2021 Consolidated Financial Statements
15th Feb 202211:35 amRNSReference Material for 2022 AGM
15th Feb 202211:24 amRNSTransaction with Affiliate Company
15th Feb 202211:21 amRNSAppointment of New Chief Executive Officer
15th Feb 202211:16 amRNSCharitable Contribution
27th Jan 20227:05 amRNSYear-End Dividend for FY2021
27th Jan 20227:00 amRNS2021 4Q Earnings Release
7th Jan 20227:00 amRNSNotice of 4Q 2021 Earnings Release Schedule
7th Jan 20227:00 amRNS4Q 2021 Pre-Earnings Guidance
1st Dec 202110:03 amRNSCharitable Contributions
30th Nov 202112:52 pmRNS2021 3Q Interim Business Report
30th Nov 202111:15 amRNSTransactions with Affiliated Companies
24th Nov 20218:11 amRNSInvestment in Fabrication Plant
10th Nov 20217:55 amRNSAnnouncement of Investor Relations Event
28th Oct 20218:22 amRNSCharitable Contribution
28th Oct 20218:18 amRNSTransaction with Affiliate Company
28th Oct 20218:04 amRNSTransaction with Affiliate Company
28th Oct 20218:03 amRNSQuarterly Dividend for Third Quarter 2021
28th Oct 20217:59 amRNS2021 3Q Earnings Release
8th Oct 20218:05 amRNSNotice of 3Q 2021 Earnings Release Schedule
8th Oct 20218:04 amRNS3Q 2021 Pre-Earnings Guidance
31st Aug 202110:39 amRNS2021 Half-year Business Report
29th Jul 20218:12 amRNSRenewal of Property & Casualty Insurance Policy
29th Jul 20218:07 amRNSQuarterly Dividend for Second Quarter 2021
29th Jul 20218:06 amRNS2021 2Q Earnings Release
7th Jul 20218:25 amRNSNotice of 2Q 2021 Earnings Release Schedule
7th Jul 20218:17 amRNS2Q 2021 Pre-Earnings Guidance
6th Jul 202110:04 amRNSSustainability Report 2021
1st Jun 20217:00 amRNS2021 1Q Interim Report
1st Jun 20217:00 amRNSCorporate Governance Report FY2020
20th May 20219:20 amRNS2020 Separate Financial Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.